Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
71
datasets available to search
ShareScore release 0.9.0
Dataset results
71 results for “amyloid β”
Research data supporting "Sequence-Dependent Self-Assembly and Structural Diversity of Islet Amyloid Polypeptide-Derived β-Sheet Fibrils"
<p>Research data supporting the publication:</p> <p>Wang, S.-T. et al., 2017, Sequence-Dependent Self-Assembly and Structural Diversity of Islet Amyloid Polypeptide-Derived β-Sheet Fibrils, ACS Nano, http://dx.doi.org/10.1021/acsnano.7b02325</p>
Altered T-cell Reactivity to β-amyloid-related Antigens in Early Alzheimer's Disease
<p>The code generated during this study is available at this online repository with free access. Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Dr. Christoph Gericke (christoph.gericke@irem.uzh.ch).</p>
Molecular dynamics trajectories and portable binary run files for the self-assembly of heparin and amyloid-β(16-22) with the ProMPT forcefield
<h1>About this repository</h1> <p>Self-assembly simulations of heparin and amyloid-β(16-22) were performed at various numbers of peptides (<em>N_pep</em>), number of heparin molecules (<em>N_hep</em>), degrees of polymerization of heparin (<em>hep_dp</em>) and rigidity factors (<em>rig_f</em>) for heparin. This repository contains one folder per system, characterized by a combination of four system variables: <em>N_pep</em>, <em>N_hep</em>, <em>hep_dp</em> and <em>rig_f. </em></p> <p>The simulations were performed on the GROMACS 2019.4 molecular dynamics engine, with the ProMPT forcefield for coarse-grained molecular dynamics. Four independent trials: <em>trial_A</em>, <em>trial_B</em>, <em>trial_C</em> and <em>trial_D</em> were performed per system, each with different starting velocities. Each trial was run for 3000 ns.</p> <h1>Contents</h1> <h2><code>> heparin_abeta_trajectories.zip</code></h2> <p>The repository contains the zip file <code>heparin_abeta_trajectories.zip</code> with 13 folders named according to the convention,<code> "{<em>N_pep</em>}pep_{<em>N_hep</em>}hep_dp{<em>hep_dp</em>}_{<em>rig_f</em>}xRigid"</code>. For example, data for the system consisting of 16 peptides (<em>N_pep</em>), 1 heparin (<em>N_hep</em>), 18 monosaccharides in length (<em>hep_dp</em>) with a rigidity factor of 100 (<em>rig_f</em>) would be stored in the directory <code>16pep_1hep_dp18_100xRigid/</code>.</p> <p>If the system did not contain heparin, <em>N_hep, hep_dp</em> and <em>rig_f</em> were set to 0 by default. For example, data for the system consisting of 16 peptides (<em>N_pep</em>) and no heparin would be stored in the directory <code>16pep_0hep_dp0_0xRigid/</code>.</p> <p>A directory such as <code>16pep_1hep_dp18_100xRigid/</code> will have the following contents:</p> <ul> <li><code><strong>solute_only.ndx</strong></code><br>Contains an index group for solute molecules (peptides and/or heparin) only.</li> <li><code><strong>trial_A/</strong></code> <ul> <li><code><strong>md.tpr</strong></code> <br>Portable run file with which the current trajectory was generated. This file may be used to reproduce the trajectory as well.</li> <li><code><strong>solute_only.cluster_center.xtc </strong></code><br>A gromacs trajectory containing only the solute molecules (peptides and/or heparin), centered with the gromacs tool <em>gmx trjconv</em></li> <li><code><strong>solute_only.tpr </strong></code><br>A gromacs portable binary input file containing data for the solute molecules (peptides and/or heparin) only, generated with the <em>gmx convert-tpr</em> tool.<br>This file may be used during analysis of the solute_only.cluster_center.xtc trajectory.</li> </ul> </li> <li><code><strong>trial_B/</strong></code><br>contents same as <code><strong>trial_A/</strong></code></li> <li><strong><code>trial_C/</code><br></strong>contents same as <code><strong>trial_A/</strong></code></li> <li><strong><code>trial_D/</code><br></strong>contents same as <code><strong>trial_A/</strong></code></li> </ul> <h2><code>> psf_files_for_VMD_visualization.zip</code></h2> <p>This zip file contains thirteen .psf files, one per system, that can be used in accord with <code>solute_only.cluster_center.xtc </code>files to visualize trajectories on the Visual Molecular Dynamics (VMD) software.</p> <p><strong>Please seek out the associated publication for essential context on these trajectories. </strong></p> <p><strong>To access the source files with which these simulations were set-up, and a brief tutorial, see: </strong><a href="https://github.com/suhasgotla/heparin_amyloid_self-assembly">https://github.com/suhasgotla/heparin_amyloid_self-assembly</a></p>
Data from: Flortaucipir PET uncovers relationships between tau and β-amyloid in aging, primary age related tauopathy, and Alzheimer disease
<p>[<sup>18</sup>F]-Flortaucipir PET is considered a good biomarker of Alzheimer's disease. However, it is unknown how flortaucipir is associated with the distribution of tau across brain regions and how these associations are influenced by β-amyloid. It is also unclear whether flortaucipir can detect tau in definite primary age-related tauopathy (PART). We identified 248 individuals at Mayo Clinic that had undergone [<sup>18</sup>F]-flortaucipir PET during life, had died, and undergone an autopsy, 239 cases of which also had β-amyloid PET. We assessed nonlinear relationships between flortaucipir uptake in nine medial temporal and cortical regions, Braak tau stage and Thal β-amyloid phase using generalized additive models. We found that flortaucipir uptake was greater with increasing tau stage in all regions. Increased uptake at low tau stages in medial temporal regions was only observed in cases with high β-amyloid phase. Flortaucipir uptake linearly increased with β-amyloid phase in medial temporal and cortical regions. The highest flortaucipir uptake occurred with high Alzheimer's disease neuropathologic change (ADNC) scores, followed by low-intermediate ADNC scores, then PART, with entorhinal cortex providing the best differentiation between groups. Flortaucipir PET had limited ability to detect PART and imaging defined PART did not correspond with pathologically defined PART. In summary, spatial patterns of flortaucipir mirrored histopathological tau distribution, were influenced by β-amyloid phase, and were useful for distinguishing different ADNC scores and PART.</p>
Accurate and Unbiased Quantitation of Amyloid-β Fluorescence Images Using ImageSURF
<p>Software tools and image files needed to reproduce the results of the image classifier evaluation in the Current Alzheimer Research manuscript of the same title.</p>
Microscopy images - " Particulate matter constituents trigger the formation of extracellular amyloid β and Tau -containing plaques and neurite shortening in vitro"
<p>This repository contains microscopy data from the manuscript "Particulate matter constituents trigger the formation of extracellular amyloid β and Tau -containing plaques and neurite shortening in vitro" by Aleksandar Sebastijanović, Laura Maria Azzurra Camassa, Vilhelm Malmborg, Slavko Kralj, Joakim Pagels, Ulla Vogel, Shan Zienolddiny-Narui, Iztok Urbančič, Tilen Koklič, and Janez Štrancar (published in Nanotoxicology, 18(4), 335–353. https://doi.org/10.1080/17435390.2024.2362367).</p> <p>Raw data are organized in folders named by image number, containing a subfolder with the date (year-day-month) of image acquisition. Followed by a subfolder named by a nanomaterial to which neurons were exposed. Each folder contains images from individual multi-channel, multi-position time-lapse experiments with different combinations of cells exposed to one nanomaterial. Files are named as: IMGxxxx_[ExperimentCode]_ROIxx_[Channel].tif, where each of the varying elements in [..] denotes the following:<br>• [ExperimentCode]: a short name of the experiment<br>• [Channel]: membrane (MEM), cytoplasm neuronal cells (NEU), nanomaterial (NANO), amyloid beta (AMY)</p>
Molecular Dynamics Simulation on the Effect of Transition Metal Binding to the N-Terminal Fragment of Amyloid-β
<p>Molecular dynamics trajectories in PDB format for 3x Cu-Aβ, 3x Zn-Aβ and 9x Fe-Aβ<strong> </strong>simulations.</p>
Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
ClinicalTrials.gov study NCT00928304. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers
ClinicalTrials.gov study NCT00750282. IPD Sharing: Not stated. Countries: 5. Publications: 2.
RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
ClinicalTrials.gov study NCT06470061. IPD Sharing: YES. Countries: 1. Publications: 7.
Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
ClinicalTrials.gov study NCT01020838. IPD Sharing: Not stated. Countries: 5. Publications: 2.
tACS for Amyloid-β Reduction in Alzheimer's Disease
ClinicalTrials.gov study NCT03290326. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau
Open the record for dataset details and reuse information.
Data from: Amyloid β induces hormetic-like effects through major stress pathways in a C. elegans model of Alzheimer’s disease
Open the record for dataset details and reuse information.
Data from: Flortaucipir PET uncovers relationships between tau and β-amyloid in aging, primary age related tauopathy, and Alzheimer disease
Open the record for dataset details and reuse information.
Data from: Elovanoids counteract oligomeric β-Amyloid-induced gene expression and protect photoreceptors
<p><span>The onset of neurodegenerative diseases activates inflammation that leads to progressive neuronal cell death and impairments in cognition (Alzheimer's disease, AD) and sight (age-related macular degeneration, AMD). How neuroinflammation can be counteracted is not known. In AMD, amyloid β-peptide (Aβ) accumulates in subretinal drusen. In the 5xFAD retina, we found early functional deficiencies (ERG) without photoreceptor cell (PRC) death and identified early insufficiency in biosynthetic pathways of pro-homeostatic/neuroprotective mediators, neuroprotectin D1 (NPD1) and elovanoids (ELVs). To mimic an inflammatory milieu in wild-type (WT) mouse, we triggered retinal pigment epithelium (RPE) damage/PRC death by subretinally injected oligomeric β-Amyloid (OAβ) and observed that ELVs administration counteracted their effects, protecting these cells. In addition, ELVs prevented OAβ-induced changes in gene expression engaged in senescence, inflammation, autophagy, extracellular matrix remodeling and AMD. Moreover, since OAβ target the RPE, we used primary human RPE cell cultures and demonstrated that OAβ caused cell damage, while ELVs protected and restored gene expression as in mouse. Our data show OAβ activates senescence as reflected by enhanced expression of p16INK4a, MMP1, p53, p21, p27 and Il-6 and of <span>senescence-associated secretory phenotype</span> (SASP) secretome, followed by RPE and PRC demise and that elovanoids 32 and 34 blunt these events and elicits protection. In addition, ELVs counteracted OAβ-induced expression of genes engaged in AMD, autophagy and extracellular matrix (ECM) remodeling. Overall, our data uncovered that ELVs downplay OAβ-senescence program induction and inflammatory transcriptional events and protect RPE cells and PRC, and therefore have potential as a possible therapeutic avenue for AMD.</span></p>
Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone
Open the record for dataset details and reuse information.
A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)
ClinicalTrials.gov study NCT02407353. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain
ClinicalTrials.gov study NCT00287248. IPD Sharing: Not stated. Countries: 1. Publications: 42.
Amyloid-β Clearance Mechanisms in Alzheimer's Disease
ClinicalTrials.gov study NCT05059158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.